Approx. Rs 5,172 / BottleGet Latest Price
Product Details:Brand | Biotest |
Usage/Application | Clinical |
Composition | Pentaglobin |
Injectable Form | Liquid |
Dose | 250 mg |
Packaging Size | 10 ml |
Medicine Type | Injection |
Product Type | Finished Product |
Gender | Unisex |
Additional Information:
Approx. Rs 23,700 / PackGet Latest Price
Product Details:Minimum Order Quantity | 1 Pack |
Brand | Hetero |
Usage/Application | Personal |
Composition | Plexrixafor |
Injectable Form | Liquid |
Dose | 1.2ml |
Packaging Size | Vial |
Medicine Type | Injection |
Product Type | Finished Product |
Gender | Unisex |
Packaging Type | Box |
Power | 1.2Ml Injection |
Shelf Life | 25 Months |
Mozobil (plerixafor) injection is a sterile, preservative-free, clear, colorless to pale-yellow, isotonic solution for subcutaneous injection. Each mL of the sterile solution contains 20 mg of plerixafor. Each single-use vial is filled to deliver 1.2 mL of the sterile solution that contains 24 mg of plerixafor and 5.9 mg of sodium chloride in Water for Injection adjusted to a pH of 6.0 to 7.5 with hydrochloric acid and with sodium hydroxide, if required.
Plerixafor is a hematopoietic stem cell mobilizer with a chemical name l, 1’-[1,4phenylenebis(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane. It has the molecular formula C28H54N8. The molecular weight of plerixafor is 502.79 g/mol.
Mozobil®(plerixafor) injection is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma (NHL) and multiple myeloma (MM).
Vials should be inspected visually for particulate matter and discoloration prior to administration and should not be used if there is particulate matter or if the solution is discolored.
Begin treatment with Mozobil after the patient has received G-CSF once daily for four days [see Recommended Concomitant Medications]. Administer Mozobil approximately 11 hours prior to initiation of each apheresis for up to 4 consecutive days.
The recommended dose of Mozobil by subcutaneous injection is based on body weight:
Use the patient’s actual body weight to calculate the volume of Mozobil to be administered. Each vial delivers 1.2 mL of 20 mg/mL solution, and the volume to be administered to patients should be calculated from the following equation:
0.012 × patient’s actual body weight (in kg) = volume to be administered (in mL)
In clinical studies, Mozobil dose has been calculated based on actual body weight in patients up to 175% of ideal body weight. Mozobil dose and treatment of patients weighing more than 175% of ideal body weight have not been investigated.
Based on increasing exposure with increasing body weight, the Mozobil dose should not exceed 40 mg/day.
Additional Information:
Approx. Rs 3,700 / UnitGet Latest Price
Product Details:Minimum Order Quantity | 1 Unit |
Brand | Baxter |
Usage/Application | Clinical |
Composition | Plasma and Serum Glycoprotein involved in blood coagulation |
Injectable Form | Lyophilized Powder |
Medicine Type | Allopathic |
Form Of Medicine | Injectable |
Human coagulation factor VIII is a preparation of plasma protein fraction that contains the glycoprotein coagulation factor VIII (plasma and serum glycoprotein involved in blood coagulation) together with varying amounts of Willebrand factor, depending on the method of preparation
Foreign NamesApprox. Rs 7,000 / PackGet Latest Price
Product Details:Minimum Order Quantity | 1 Pack |
Packaging Size | 0.1ml |
Brand | SEPSIVAC INJ |
Manufacturer | CADILA PHARMA |
Composition | MYCOBACTERIUM W (HEAT KILLED) |
Treatment | COVID19 |
Prescription/Non prescription | Prescription |
Usage/Application | CORONA INJ |
Country of Origin | Made in India |
To revolutionize Sepsis management, Cadila Pharmaceuticals introduces Sepsivac, an immunotherapy treatment. Its the first-in-the-world innovation in Sepsis management and the drug has received approval from Drug Controller General of India (DCGI) for immunotherapy treatment in Sepsis or septic shock.
Sepsivac contains mycobacterium w, an immunomodulator which is a non-pathogenic mycobacterium. As a result of the immunomodulator effect, Sepsivac effectively saves more lives in sepsis. Randomized trials in sepsis patients showed 11% absolute reduction and 55.5% relative reduction in mortality. Sepsivac reduces the days on ventilator, ICU stay, hospital stay, incidences of secondary infection and days on vasopressor & reduces the SOFA score.
Product Price :Get Latest Price
Product Details:Usage | Clinical and Hospital |
Packaging Type | Glass Bottle |
Medicine Type | Allopathic |
Composition | Caffeine Citrate Injection USP |
Dose | 20 mg/3 ml |
Additional Information:
Product Price :Get Latest Price
Product Details:Packaging Size | Vial |
Manufacturer | Allergan |
Composition | Botulinus Toxin |
Brand | Botox Injection |
Prescription/Non prescription | Prescription |
Packaging Type | Vial |
Product Type | Finished Product |
Storage | Cold Storage |
Additional Information:
Product Price :Get Latest Price
Product Details:Manufacturer | BOHRINGER INGHELIUM |
Treatment | FOR DIABETICS |
Prescription/Non prescription | Prescription |
Product Type | Finished Product |
Usage | Hospital, Clinical, Personal |
Packaging Size | 6 x 10 Capsules |
Form | Tablet |
Composition | Dabigatran Etexilate mesilate |
Available Dose | 110,150 mg |
Additional Information:
Explore More Products
4.0/5
Rated by 214 Users
© D. Vijay Pharma Private Limited. All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited